Avandia FDA

Zoloft Lawsuit Information : Pregnancy Birth Defect Zoloft Attorney

8 December, 2011

The bad drug lawsuit attorneys at AvandiaRecallNews.com no longer are accepting new Avandia cases. We continue to help families affected by Zoloft birth defects.

Our lawyers are accepting and aggressively litigating nationwide Zoloft Lawsuit claims to collect damages for Zoloft birth defects.

Call us now at 800-845-6913 or click this link for Zoloft Lawsuit Information.

Let us help you and your child recover the Zoloft birth defects compensation you deserve.

Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Safety | Avandia Senate Report | Avandia Settlements | Avandia Side Effects | Avandia Warning | Congestive Heart Failure

Avandia statute of limitations ruling allows new lawsuits to proceed

16 October, 2011

A federal judge presiding over Avandia litigation denied drug maker GlaxoSmithKline’s motion to dismiss 60 Avandia lawsuits on statute of limitations grounds. GSK attempted to convince the judge that the claims were filed too late. Continue reading Avandia statute of limitations ruling allows new lawsuits to proceed

Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Settlements | Avandia Side Effects

Avandia recall in New Zealand: 2011 Avandia settlements in U.S.

17 February, 2011

The New Zealand Ministry of Health will withdraw Avandia from the market due to heart risks. The Avandia recall is scheduled for April 29. Drug regulators at the U.S. FDA have fallen short of ordering an Avandia recall. 2011 Avandia settlements have been reached in thousands of cases. Avandia lawsuits continue to be filed across the United States. Continue reading Avandia recall in New Zealand: 2011 Avandia settlements in U.S.

Category: Avandia FDA | Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Settlements

Avandia Lawsuits Attorney for Heart Attack Injury Settlements

29 December, 2010

Drug maker GlaxoSmithKline has agreed to pay hundreds of millions of dollars to settle Avandia heart attack lawsuits. Settlement claims continue being made on new Avandia heart attack cases. Avandia lawsuit attorneys have won settlements on cases to recover financial compensation for Avandia heart attacks. Lawsuits continue to be filed against GSK on claims that diabetes drugs containing Rosigitazone caused heart attack injury and wrongful death damages. Continue reading Avandia Lawsuits Attorney for Heart Attack Injury Settlements

Category: Avandia FDA | Avandia Lawsuit | Avandia Settlements | Avandia Side Effects

Avandia Timeline: Diabetes Drug Side Effects, FDA Warnings

18 November, 2010

Since its FDA approval in 1999, Avandia heart attack, stroke, heart failure and heart related death side effects have led to safety alerts, black box warnings, and bad drug lawsuit settlements.

A timeline of events alerting diabetes patients, the FDA and Avandia lawsuit attorneys of the heart attack and other cardiovascular risks associated with the diabetes drug. Continue reading Avandia Timeline: Diabetes Drug Side Effects, FDA Warnings

Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia Senate Report | Avandia Side Effects

GSK under state, federal criminal investigations of Avandia

24 October, 2010

Avandia drug maker GlaxoSmithKline is under investigation by federal and state law enforcement officials, the company announced in a press release issued on October 21, 2010:

[GSK] is in the process of responding to a US Department of Justice (DOJ) subpoena relating to the development and marketing of Avandia. Continue reading GSK under state, federal criminal investigations of Avandia

Category: Avandia FDA | Avandia Lawsuit | Avandia News | Avandia Recall | Avandia Settlements

FDA Avandia news conference: 2010 rosiglitazone restrictions

15 October, 2010

A FDA Avandia news conference was held on September 23, 2010 to announce the FDA decision on Avandia and for FDA drug safety officials to take questions from the media.

The following is a complete transcript of the news conference. FDA Commissioner Margaret Hamburg, FDA Principal Deputy Commissioner Joshua Sharfstein and Janet Woodcock, Director of the Center for Drug Evaluation and Research at FDA all were in attendance. Continue reading FDA Avandia news conference: 2010 rosiglitazone restrictions

Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia News | Avandia Recall | Avandia Safety | Avandia Warning

FDA Avandia heart attack news, Avandia critic reacts to FDA

8 October, 2010

In May 2007, Cleveland Clinic cardiologist Dr. Steven Nissen published an Avandia study in the New England Journal of Medicine that would mark a turning point for the diabetes drug Avandia.

Dr. Nissen found that Avandia use was linked to a 43% increased risk of heart attack. and has been a vocal critic of Avandia ever since. Dr. Nissen reacts to the September 23, 2010 FDA Avandia restrictions. Continue reading FDA Avandia heart attack news, Avandia critic reacts to FDA

Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia News | Avandia Safety | Avandia Settlements | Avandia Warning

Avandia Recall News: GSK hid Rosiglitazone side effects risks

30 September, 2010

Last week, an Avandia recall in Europe was announced as the FDA put tight new restrictions on Avandia use in the United States.

Avandia has been on the market in the U.S. to treat type 2 diabetes since 1999. How long have drug maker GlaxoSmithKline and the FDA been aware of Avandia side effects risks? According to a lead Senate investigator, the answer is shocking. Continue reading Avandia Recall News: GSK hid Rosiglitazone side effects risks

Category: Avandia FDA | Avandia Lawsuit | Avandia News | Avandia Senate Report | Avandia Settlements | Avandia Side Effects

FDA stops Avandia TIDE trial due to unjustified heart risks

25 September, 2010

FDA stops Avandia TIDE trial due to unjustified risk of stroke and cardiac events.

Act now to make you Avandia settlement claim. FDA drug safety experts concluded that the TIDE trial subjected participants to an unjustified risk of heart disease. All of the regulatory deadlines set by the FDA for completion of the trial have been rescinded. Continue reading FDA stops Avandia TIDE trial due to unjustified heart risks

Category: Avandia Cardiovascular Risk | Avandia FDA | Avandia News | Avandia Safety
Recent Comments
  • SEABEECH: Peace be with you. My dad died at 11:22 on December 21, 201...
  • vertee jackson jr: The company hired to save (GSK) money is using a point syste...
  • E. Tan: I am from the Philippines and my mother, a diabetic for more...
  • A. Held: "Documents released earlier this year by the Senate Finance ...
  • Robert: I was 37 and had to have Quadruple bypass in Oct 2005. I was...